icon-folder.gif   Conference Reports for NATAP  
 
  15th European AIDS Conference (EACS)
October 21-24, 2015
Barcelona
Back grey_arrow_rt.gif
 
 
 
Dual therapy with Lopinavir/ Ritonavir (LPV/r) and Lamivudine (3TC) is non-inferior to standard triple drug therapy in Na´ve HIV-1 infected subjects : 48-week results of the GARDEL Study.
 
 
  Reported by Jules Levin
EACS 2015 Oct 21-24 Barcelona, Spain - 15th European AIDS Conference
 
Pedro Cahn on behalf of the GARDEL study group

EACS1.gif

EACS2.gif

EACS3.gif

EACS4.gif

EACS5.gif

EACS6.gif

EACS7.gif

EACS8.gif

EACS9.gif

EACS10.gif

EACS11.gif

EACS12.gif

EACS13.gif

EACS14.gif

EACS15.gif

EACS16.gif

EACS17.gif